CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Children's Hospital Association Responds to H-1B Visa Program Changes
New Toolkit to Strengthen Medicaid EPSDT Implementation
CHA Responds to HHS’ Changes to Vaccine Recommendations
Children's Hospital Association Responds to H-1B Visa Program Changes
CHA has submitted a letter to the administration highlighting the impact of H-1B Visa changes on the pediatric workforce.
Jan. 08, 2026
New Toolkit to Strengthen Medicaid EPSDT Implementation
An upcoming Children’s Hospital Association resource will help pediatric hospitals identify and authorize mental health services and address gaps in state Medicaid implementation.
Jan. 06, 2026
CHA Responds to HHS’ Changes to Vaccine Recommendations
Any changes to the childhood vaccine schedule should be guided by the best available evidence for the long-term health of children.
Jan. 05, 2026
